Healthpeak Properties Key Executives
This section highlights Healthpeak Properties's key executives, including their titles and compensation details.
Find Contacts at Healthpeak Properties
(Showing 0 of )
Healthpeak Properties Earnings
This section highlights Healthpeak Properties's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q4 | 2024 | 2025-02-04 | N/A | N/A |
| Read Transcript | Q3 | 2024 | 2024-10-25 | N/A | N/A |
| Read Transcript | Q2 | 2024 | 2024-07-26 | N/A | N/A |
| Read Transcript | Q1 | 2024 | 2024-04-26 | N/A | N/A |
| Read Transcript | Q4 | 2023 | 2024-02-09 | N/A | N/A |
| Read Transcript | Q2 | 2023 | 2023-08-03 | N/A | N/A |
| Read Transcript | Q1 | 2023 | 2023-05-04 | N/A | N/A |
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Medical Office and Senior Housing, designed to provide stability through the inevitable industry cycles. At Healthpeak, we pair our deep understanding of the healthcare real estate market with a strong vision for long-term growth.
$17.10
Stock Price
$9.36B
Market Cap
387
Employees
Denver, CO
Location
Financial Statements
Access annual & quarterly financial statements for Healthpeak Properties, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $2.70B | $2.18B | $526.63M | $457.70M | $437.50M |
| Cost of Revenue | $1.07B | $902.66M | $171.10M | $137.41M | $128.20M |
| Gross Profit | $1.63B | $1.28B | $355.54M | $320.29M | $309.31M |
| Gross Profit Ratio | 60.20% | 58.60% | 67.51% | 70.00% | 70.70% |
| Research and Development Expenses | $- | $- | $0 | $0 | $0 |
| General and Administrative Expenses | $97.16M | $95.13M | $40.21M | $37.76M | $33.76M |
| Selling and Marketing Expenses | $- | $8.00M | $7.90M | $8.00M | $6.00M |
| Selling General and Administrative Expenses | $97.16M | $103.13M | $40.21M | $37.76M | $33.76M |
| Other Expenses | $1.53B | $- | $189.64M | $157.87M | $149.59M |
| Operating Expenses | $1.63B | $103.13M | $229.85M | $195.63M | $183.35M |
| Cost and Expenses | $2.70B | $1.01B | $400.95M | $333.04M | $311.55M |
| Interest Income | $- | $- | $- | $- | $- |
| Interest Expense | $280.43M | $200.33M | $172.94M | $157.98M | $218.34M |
| Depreciation and Amortization | $1.06B | $749.90M | $1.71B | $1.58B | $1.47B |
| EBITDA | $1.61B | $1.19B | $314.54M | $280.96M | $1.13B |
| EBITDA Ratio | 59.65% | 54.54% | 59.73% | 61.39% | 62.69% |
| Operating Income | $- | $1.18B | $124.89M | $123.09M | $124.70M |
| Operating Income Ratio | 0.00% | 53.88% | 23.72% | 26.89% | 28.50% |
| Total Other Income Expenses Net | $273.17M | $-860.27M | $-585.65M | $-894.39M | $-533.07M |
| Income Before Tax | $273.17M | $314.94M | $110.04M | $86.78M | $68.49M |
| Income Before Tax Ratio | 10.12% | 14.44% | 20.89% | 18.96% | 15.65% |
| Income Tax Expense | $4.35M | $-9.62M | $72.23M | $61.38M | $58.29M |
| Net Income | $243.14M | $306.01M | $37.80M | $25.40M | $10.20M |
| Net Income Ratio | 9.00% | 14.03% | 7.18% | 5.55% | 2.33% |
| EPS | $0.36 | $0.56 | $0.07 | $0.05 | $0.02 |
| EPS Diluted | $0.36 | $0.56 | $0.07 | $0.05 | $0.02 |
| Weighted Average Shares Outstanding | 675.68M | 547.01M | 538.81M | 538.93M | 204.24M |
| Weighted Average Shares Outstanding Diluted | 676.23M | 547.27M | 539.15M | 539.24M | 211.15M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $697.99M | $700.40M | $695.50M | $606.56M | $135.47M | $138.55M | $135.10M | $134.34M | $132.56M | $131.51M | $132.17M | $130.39M | $116.12M | $115.31M | $112.92M | $113.34M | $111.44M | $109.57M | $109.07M | $107.43M |
| Cost of Revenue | $277.03M | $280.28M | $557.33M | $462.95M | $6.97M | $47.62M | $45.08M | $45.39M | $43.02M | $43.65M | $42.68M | $41.75M | $34.34M | $35.68M | $33.46M | $33.93M | $33.70M | $32.50M | $31.03M | $30.96M |
| Gross Profit | $420.96M | $420.12M | $138.18M | $143.61M | $128.50M | $90.92M | $90.03M | $88.95M | $89.55M | $87.87M | $89.49M | $88.64M | $81.78M | $79.63M | $79.47M | $79.41M | $77.74M | $77.06M | $78.04M | $76.47M |
| Gross Profit Ratio | 60.31% | 60.00% | 19.90% | 23.70% | 94.90% | 65.60% | 66.60% | 66.20% | 67.50% | 66.80% | 67.70% | 68.00% | 70.40% | 69.10% | 70.40% | 70.10% | 69.76% | 70.33% | 71.55% | 71.18% |
| Research and Development Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| General and Administrative Expenses | $23.93M | $23.22M | $26.72M | $23.30M | $7.62M | $9.77M | $10.16M | $11.20M | $9.81M | $10.08M | $10.03M | $10.29M | $9.64M | $9.53M | $9.12M | $9.46M | $8.20M | $8.35M | $8.24M | $8.98M |
| Selling and Marketing Expenses | $- | $- | $- | $- | $8.00M | $- | $- | $- | $7.90M | $- | $- | $- | $8.00M | $- | $- | $- | $6.00M | $- | $- | $- |
| Selling General and Administrative Expenses | $23.93M | $23.22M | $26.72M | $23.30M | $7.62M | $9.77M | $10.16M | $11.20M | $9.81M | $10.08M | $10.03M | $10.29M | $9.64M | $9.53M | $9.12M | $9.46M | $8.20M | $8.35M | $8.24M | $8.98M |
| Other Expenses | $397.03M | $- | $4.00M | $-34.76M | $29.97M | $25.24M | $24.17M | $47.68M | $47.64M | $47.04M | $47.70M | $47.26M | $43.21M | $38.58M | $38.10M | $37.98M | $37.85M | $37.95M | $37.05M | $36.75M |
| Operating Expenses | $420.96M | $420.12M | $310.22M | $34.76M | $37.60M | $57.70M | $58.11M | $58.88M | $57.45M | $57.12M | $57.73M | $57.55M | $52.85M | $48.12M | $47.22M | $47.44M | $46.04M | $46.30M | $45.29M | $45.72M |
| Cost and Expenses | $697.99M | $583.51M | $583.49M | $497.70M | $44.57M | $105.33M | $103.18M | $104.27M | $100.47M | $100.77M | $100.41M | $99.31M | $87.19M | $83.80M | $80.68M | $81.38M | $79.75M | $78.80M | $76.32M | $76.69M |
| Interest Income | $- | $14.30M | $7.83M | $5.75M | $- | $5.36M | $5.28M | $6.16M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Interest Expense | $70.51M | $74.11M | $74.91M | $60.91M | $52.78M | $50.51M | $49.07M | $47.96M | $49.41M | $44.08M | $41.87M | $37.59M | $36.55M | $35.91M | $38.68M | $46.84M | $46.17M | $53.73M | $54.82M | $55.69M |
| Depreciation and Amortization | $274.47M | $280.02M | $283.50M | $219.22M | $188.54M | $184.56M | $197.57M | $179.22M | $179.16M | $173.19M | $180.49M | $177.73M | $178.11M | $177.18M | $171.46M | $37.99M | $37.85M | $37.95M | $37.05M | $36.75M |
| EBITDA | $341.74M | $452.63M | $395.51M | $328.07M | $307.69M | $300.38M | $297.02M | $275.62M | $242.78M | $274.92M | $277.50M | $267.00M | $239.21M | $255.77M | $261.40M | $247.81M | $109.27M | $115.02M | $240.46M | $162.93M |
| EBITDA Ratio | 48.96% | 64.63% | 56.87% | 54.09% | 102.19% | 58.37% | 60.45% | 57.68% | 59.89% | 59.10% | 61.10% | 61.17% | 61.82% | 60.45% | 61.94% | 61.34% | 62.04% | 62.18% | 63.89% | 62.68% |
| Operating Income | $- | $116.88M | $112.01M | $108.86M | $90.91M | $90.92M | $33.72M | $29.81M | $31.76M | $30.68M | $31.53M | $30.92M | $46.68M | $31.52M | $32.25M | $31.96M | $31.70M | $30.77M | $32.75M | $30.74M |
| Operating Income Ratio | 0.00% | 16.69% | 16.11% | 17.95% | 67.10% | 65.63% | 24.96% | 22.19% | 23.96% | 23.33% | 23.86% | 23.71% | 40.19% | 27.33% | 28.56% | 28.20% | 28.44% | 28.08% | 30.03% | 28.62% |
| Total Other Income Expenses Net | $-3.23M | $-18.37M | $-238.76M | $-219.64M | $-241.18M | $-230.94M | $-42.87M | $-140.81M | $-57.51M | $80.85M | $-29.42M | $-15.84M | $-51.55M | $-20.55M | $-94.96M | $-212.97M | $-151.74M | $-92.72M | $27.70M | $29.64M |
| Income Before Tax | $-3.23M | $98.51M | $155.39M | $22.50M | $6.79M | $12.89M | $13.09M | $10.67M | $11.88M | $66.28M | $17.93M | $13.94M | $28.25M | $22.05M | $18.68M | $17.80M | $18.61M | $16.48M | $18.44M | $14.96M |
| Income Before Tax Ratio | -0.46% | 14.06% | 22.34% | 3.71% | 5.02% | 9.30% | 9.69% | 7.94% | 8.96% | 50.40% | 13.57% | 10.69% | 24.33% | 19.12% | 16.54% | 15.71% | 16.70% | 15.04% | 16.91% | 13.93% |
| Income Tax Expense | $-14.01M | $1.94M | $2.73M | $13.70M | $-11.84M | $20.33M | $22.98M | $59.59M | $19.88M | $18.30M | $17.23M | $16.82M | $19.38M | $13.79M | $13.71M | $13.91M | $13.88M | $13.68M | $14.71M | $16.02M |
| Net Income | $4.55M | $85.67M | $146.05M | $6.68M | $6.79M | $12.34M | $12.54M | $-48.93M | $-8.00M | $47.98M | $698.00K | $-2.88M | $27.29M | $21.36M | $18.11M | $17.19M | $17.98M | $15.90M | $17.82M | $14.41M |
| Net Income Ratio | 0.65% | 12.23% | 21.00% | 1.10% | 5.02% | 8.90% | 9.28% | -36.42% | -6.03% | 36.48% | 0.53% | -2.21% | 23.50% | 18.53% | 16.04% | 15.17% | 16.14% | 14.51% | 16.34% | 13.42% |
| EPS | $0.01 | $0.12 | $0.21 | $0.01 | $0.01 | $0.02 | $0.02 | $-0.09 | $0.00 | $0.09 | $0.00 | $-0.01 | $0.12 | $0.10 | $0.08 | $0.08 | $0.08 | $0.07 | $0.09 | $0.07 |
| EPS Diluted | $0.01 | $0.12 | $0.21 | $0.01 | $0.01 | $0.02 | $0.02 | $-0.09 | $-0.01 | $0.09 | $0.00 | $-0.01 | $0.12 | $0.10 | $0.08 | $0.08 | $0.08 | $0.07 | $0.09 | $0.07 |
| Weighted Average Shares Outstanding | 675.68M | 699.35M | 702.93M | 647.70M | 547.10M | 547.06M | 575.00M | 546.84M | 537.99M | 544.39M | 542.21M | 539.35M | 220.69M | 217.41M | 215.84M | 210.53M | 208.82M | 208.19M | 203.69M | 196.21M |
| Weighted Average Shares Outstanding Diluted | 676.23M | 700.15M | 703.27M | 601.19M | 547.36M | 547.33M | 547.29M | 547.11M | 538.40M | 546.01M | 539.82M | 539.59M | 228.04M | 223.99M | 222.66M | 217.32M | 215.92M | 215.13M | 210.41M | 202.84M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $119.82M | $117.64M | $7.73M | $9.88M | $2.52M |
| Short Term Investments | $- | $21.36M | $2.04M | $397.00K | $- |
| Cash and Short Term Investments | $119.82M | $138.99M | $7.73M | $9.88M | $2.52M |
| Net Receivables | $794.00M | $274.27M | $428.27M | $464.50M | $237.64M |
| Inventory | $- | $- | $-12.57M | $1.96M | $117.58M |
| Other Current Assets | $72.33M | $169.37M | $479.50M | $90.64M | $2.69B |
| Total Current Assets | $986.14M | $582.64M | $124.21M | $134.63M | $206.07M |
| Property Plant Equipment Net | $424.17M | $240.16M | $231.22M | $235.48M | $137.18M |
| Goodwill | $- | $- | $18.00M | $18.00M | $18.00M |
| Intangible Assets | $817.25M | $314.16M | $505.33M | $498.22M | $406.94M |
| Goodwill and Intangible Assets | $817.25M | $314.16M | $505.33M | $498.22M | $406.94M |
| Long Term Investments | $936.81M | $782.85M | $77.72M | $69.79M | $77.75M |
| Tax Assets | $- | $- | $98.98M | $4.11B | $3.44B |
| Other Non-Current Assets | $16.77B | $13.80B | $4.06B | $131.58M | $144.00M |
| Total Non-Current Assets | $18.95B | $15.14B | $4.97B | $5.05B | $4.21B |
| Other Assets | $- | $-21.36M | $- | $- | $- |
| Total Assets | $19.94B | $15.70B | $5.10B | $5.18B | $4.41B |
| Account Payables | $275.97M | $240.26M | $265.60M | $227.64M | $269.14M |
| Short Term Debt | $150.00M | $23.97M | $90.09M | $5.05M | $129.59M |
| Tax Payables | $- | $- | $23.30M | $23.49M | $23.44M |
| Deferred Revenue | $- | $-16.95M | $- | $- | $774.32M |
| Other Current Liabilities | $449.37M | $1.11B | $-38.40M | $1.68B | $883.77M |
| Total Current Liabilities | $875.34M | $1.38B | $340.59M | $417.79M | $563.37M |
| Long Term Debt | $8.87B | $7.08B | $6.71B | $6.37B | $6.48B |
| Deferred Revenue Non-Current | $940.14M | $905.63M | $21.06M | $22.71M | $22.25M |
| Deferred Tax Liabilities Non-Current | $- | $-16.95M | $364.71M | $-22.71M | $-22.25M |
| Other Non-Current Liabilities | $191.88M | $467.88M | $-5.79B | $650.68M | $427.35M |
| Total Non-Current Liabilities | $10.01B | $8.45B | $1.76B | $1.77B | $1.11B |
| Other Liabilities | $- | $-1.05B | $- | $- | $- |
| Total Liabilities | $10.88B | $8.77B | $2.10B | $2.19B | $1.67B |
| Preferred Stock | $- | $- | $- | $- | $4.94M |
| Common Stock | $699.49M | $547.16M | $2.33M | $2.25M | $2.10M |
| Retained Earnings | $- | $- | $-881.67M | $-776.00M | $-658.17M |
| Accumulated Other Comprehensive Income Loss | $28.82M | $-4.60B | $5.18M | $-892.00K | $-5.86M |
| Other Total Stockholders Equity | $7.67B | $10.41B | $6.08B | $5.98B | $6.20B |
| Total Stockholders Equity | $8.40B | $6.35B | $2.87B | $2.84B | $2.64B |
| Total Equity | $9.06B | $6.92B | $3.00B | $2.99B | $2.74B |
| Total Liabilities and Stockholders Equity | $19.94B | $15.70B | $5.10B | $5.18B | $4.41B |
| Minority Interest | $656.35M | $574.42M | $127.39M | $157.81M | $101.99M |
| Total Liabilities and Total Equity | $19.94B | $15.70B | $5.10B | $5.18B | $4.41B |
| Total Investments | $936.81M | $782.85M | $77.72M | $69.79M | $77.75M |
| Total Debt | $9.02B | $7.08B | $1.92B | $2.02B | $1.51B |
| Net Debt | $8.90B | $6.97B | $1.92B | $2.01B | $1.51B |
Balance Sheet Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $119.82M | $180.43M | $159.29M | $157.16M | $117.64M | $195.77M | $245.66M | $3.36M | $7.73M | $2.51M | $401.00K | $2.73M | $9.88M | $5.37M | $1.52M | $3.95M | $2.52M | $3.67M | $3.89M | $2.61M |
| Short Term Investments | $- | $61.62M | $50.30M | $47.44M | $21.36M | $14.73M | $6.75M | $1.65M | $2.04M | $2.07M | $80.59M | $2.39M | $397.00K | $196.00K | $244.00K | $- | $- | $- | $- | $- |
| Cash and Short Term Investments | $119.82M | $242.04M | $159.29M | $157.16M | $117.64M | $195.77M | $245.66M | $3.36M | $7.73M | $2.51M | $401.00K | $2.73M | $9.88M | $5.37M | $1.52M | $3.95M | $2.52M | $3.67M | $3.89M | $2.61M |
| Net Receivables | $794.00M | $742.57M | $654.14M | $336.37M | $274.27M | $59.09M | $53.47M | $300.85M | $428.27M | $437.95M | $461.30M | $463.86M | $464.50M | $455.76M | $470.89M | $779.02M | $237.64M | $294.38M | $327.21M | $305.69M |
| Inventory | $- | $- | $-50.30M | $-47.44M | $612.67M | $-14.73M | $-6.75M | $-1.64M | $-12.57M | $-15.30M | $80.59M | $-2.39M | $-10.69M | $-196.00K | $-8.37M | $-9.26M | $-10.91M | $1 | $-8.64M | $-10.27M |
| Other Current Assets | $72.33M | $61.62M | $52.41M | $55.40M | $169.37M | $284.61M | $279.06M | $301.14M | $479.50M | $489.99M | $535.42M | $495.67M | $90.64M | $158.71M | $375.86M | $1.44B | $2.69B | $2.32B | $484.39M | $378.42M |
| Total Current Assets | $986.14M | $1.05B | $494.43M | $493.52M | $561.28M | $286.79M | $342.92M | $129.96M | $124.21M | $132.73M | $284.59M | $212.90M | $134.63M | $342.02M | $183.18M | $216.58M | $206.07M | $290.64M | $171.25M | $147.64M |
| Property Plant Equipment Net | $424.17M | $427.71M | $440.56M | $434.01M | $240.16M | $227.97M | $229.11M | $230.25M | $231.22M | $232.32M | $233.28M | $234.34M | $235.48M | $141.97M | $140.86M | $136.59M | $137.18M | $137.69M | $138.28M | $138.86M |
| Goodwill | $- | $- | $47.00M | $65.16M | $18.00M | $- | $- | $- | $18.00M | $- | $- | $- | $18.00M | $- | $- | $- | $- | $- | $- | $- |
| Intangible Assets | $817.25M | $898.38M | $1.08B | $1.16B | $314.16M | $509.47M | $408.95M | $505.07M | $505.33M | $505.33M | $493.15M | $498.22M | $498.22M | $192.04M | $409.16M | $405.60M | $406.94M | $213.87M | $397.01M | $397.13M |
| Goodwill and Intangible Assets | $817.25M | $898.38M | $1.08B | $1.16B | $314.16M | $509.47M | $408.95M | $505.07M | $505.33M | $505.33M | $493.15M | $498.22M | $498.22M | $192.04M | $409.16M | $405.60M | $406.94M | $213.87M | $397.01M | $397.13M |
| Long Term Investments | $936.81M | $931.84M | $927.20M | $930.56M | $782.85M | $72.07M | $73.80M | $75.09M | $77.72M | $79.61M | $80.59M | $75.67M | $69.79M | $78.56M | $73.41M | $75.54M | $77.75M | $61.11M | $62.68M | $64.32M |
| Tax Assets | $- | $- | $16.36B | $16.23B | $13.03B | $3.95B | $4.08B | $- | $98.98M | $- | $- | $- | $4.11B | $3.63B | $3.43B | $3.41B | $3.44B | $3.61B | $3.43B | $3.46B |
| Other Non-Current Assets | $16.77B | $16.73B | $876.70M | $1.29B | $772.04M | $166.14M | $149.69M | $4.12B | $4.06B | $4.19B | $4.03B | $4.09B | $131.58M | $25.21M | $125.36M | $124.61M | $144.00M | $23.02M | $134.42M | $133.43M |
| Total Non-Current Assets | $18.95B | $18.99B | $19.69B | $20.05B | $15.14B | $4.93B | $4.94B | $4.93B | $4.97B | $5.01B | $4.84B | $4.90B | $5.05B | $4.07B | $4.17B | $4.15B | $4.21B | $4.04B | $4.16B | $4.19B |
| Other Assets | $- | $-61.62M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $19.94B | $19.97B | $20.18B | $20.54B | $15.70B | $5.21B | $5.28B | $5.06B | $5.10B | $5.14B | $5.13B | $5.12B | $5.18B | $4.41B | $4.36B | $4.37B | $4.41B | $4.33B | $4.33B | $4.34B |
| Account Payables | $275.97M | $329.74M | $267.99M | $303.82M | $240.26M | $260.48M | $211.67M | $224.09M | $265.60M | $264.45M | $209.18M | $215.10M | $227.64M | $252.14M | $688.46M | $241.82M | $269.14M | $834.52M | $847.08M | $856.03M |
| Short Term Debt | $150.00M | $- | $-1.25B | $1.25B | $720.00M | $-1.01B | $340.00M | $644.76M | $90.09M | $1.29M | $2.54M | $3.78M | $5.05M | $8.73M | $730.16M | $1.05B | $129.59M | $- | $- | $- |
| Tax Payables | $- | $- | $- | $- | $- | $30.89M | $22.10M | $18.98M | $23.30M | $29.17M | $20.07M | $17.97M | $23.49M | $27.03M | $20.46M | $16.63M | $23.44M | $24.71M | $18.66M | $15.72M |
| Deferred Revenue | $- | $903.37M | $907.85M | $923.68M | $416.94M | $879.17M | $881.87M | $878.44M | $- | $- | $- | $- | $38.01M | $27.03M | $63.69M | $60.35M | $70.20M | $24.71M | $63.31M | $62.67M |
| Other Current Liabilities | $449.37M | $420.14M | $-837.82M | $-2.10B | $417.67M | $-702.12M | $438.04M | $-858.36M | $-38.40M | $2.04B | $1.94B | $1.80B | $1.68B | $1.48B | $-370.36M | $755.19M | $141.20M | $-40.94M | $17.20M | $21.20M |
| Total Current Liabilities | $875.34M | $1.65B | $1.64B | $1.82B | $1.38B | $554.59M | $550.57M | $295.94M | $340.59M | $414.30M | $367.82M | $346.08M | $417.79M | $499.44M | $463.21M | $528.85M | $563.37M | $436.00M | $454.05M | $529.63M |
| Long Term Debt | $8.87B | $8.89B | $8.89B | $9.27B | $7.08B | $6.78B | $6.69B | $6.66B | $6.71B | $6.79B | $6.65B | $6.54B | $6.37B | $5.72B | $5.22B | $5.94B | $6.35B | $6.55B | $6.90B | $6.54B |
| Deferred Revenue Non-Current | $940.14M | $- | $907.85M | $923.68M | $905.63M | $23.54M | $25.11M | $29.04M | $21.06M | $24.56M | $25.10M | $24.92M | $22.71M | $18.61M | $21.59M | $23.66M | $22.25M | $17.25M | $15.88M | $20.55M |
| Deferred Tax Liabilities Non-Current | $- | $- | $540.84M | $1.42B | $- | $-38.02M | $-25.11M | $- | $- | $- | $- | $- | $-22.71M | $10.37M | $-21.59M | $-23.66M | $-22.25M | $18.12M | $-15.88M | $-20.55M |
| Other Non-Current Liabilities | $191.88M | $1.86B | $1.51B | $1.29B | $467.88M | $1.39B | $1.43B | $810.07M | $-5.79B | $-989.85M | $-840.40M | $-710.94M | $650.68M | $-433.51M | $-165.71M | $-480.32M | $-6.02B | $219.19M | $863.17M | $826.57M |
| Total Non-Current Liabilities | $10.01B | $10.75B | $9.12B | $9.12B | $7.40B | $1.71B | $1.74B | $1.74B | $1.76B | $1.76B | $1.81B | $1.81B | $1.77B | $1.15B | $1.10B | $1.10B | $1.11B | $1.15B | $1.11B | $1.11B |
| Other Liabilities | $- | $-1.65B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $10.88B | $10.75B | $10.76B | $10.94B | $8.77B | $2.26B | $2.29B | $2.04B | $2.10B | $2.17B | $2.18B | $2.16B | $2.19B | $1.64B | $1.57B | $1.63B | $1.67B | $1.59B | $1.56B | $1.64B |
| Preferred Stock | $- | $- | $4.84B | $4.08B | $3.02B | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $699.49M | $699.40M | $700.32M | $703.73M | $547.16M | $2.38M | $2.38M | $2.38M | $2.33M | $2.27M | $2.26M | $2.25M | $2.25M | $2.17M | $2.17M | $2.13M | $2.10M | $2.08M | $2.08M | $2.03M |
| Retained Earnings | $- | $- | $-4.84B | $-4.78B | $-1.06B | $-1.01B | $-969.74M | $-926.79M | $-881.67M | $-838.73M | $-850.10M | $-814.49M | $-776.00M | $-751.15M | $-722.59M | $-689.77M | $-658.17M | $-627.88M | $-595.12M | $-563.74M |
| Accumulated Other Comprehensive Income Loss | $28.82M | $-12.38M | $42.30M | $38.54M | $19.37M | $15.22M | $9.28M | $4.16M | $5.18M | $5.32M | $3.57M | $487.00K | $-892.00K | $-4.05M | $-4.52M | $-5.06M | $-5.86M | $-6.31M | $-6.91M | $-5.67M |
| Other Total Stockholders Equity | $7.67B | $7.88B | $12.86B | $17.70B | $15.03B | $5.87B | $5.96B | $6.04B | $6.08B | $5.90B | $5.77B | $5.87B | $5.98B | $6.13B | $6.35B | $6.23B | $2.11B | $6.30B | $6.56B | $6.70B |
| Total Stockholders Equity | $8.40B | $8.56B | $8.76B | $8.88B | $6.35B | $2.82B | $2.86B | $2.89B | $2.87B | $2.82B | $2.79B | $2.80B | $2.84B | $2.69B | $2.72B | $2.66B | $2.64B | $2.64B | $2.67B | $2.60B |
| Total Equity | $9.06B | $9.22B | $9.42B | $9.60B | $6.92B | $2.95B | $2.99B | $3.02B | $3.00B | $2.97B | $2.95B | $2.96B | $2.99B | $2.76B | $2.79B | $2.74B | $2.74B | $2.74B | $2.77B | $2.70B |
| Total Liabilities and Stockholders Equity | $19.94B | $19.97B | $20.18B | $20.54B | $15.70B | $5.21B | $5.28B | $5.06B | $5.10B | $5.14B | $5.13B | $5.12B | $5.18B | $4.41B | $4.36B | $4.37B | $4.41B | $4.33B | $4.33B | $4.34B |
| Minority Interest | $656.35M | $659.16M | $661.27M | $717.89M | $574.42M | $128.46M | $130.19M | $131.39M | $127.39M | $150.82M | $153.76M | $155.64M | $157.81M | $74.23M | $74.87M | $78.25M | $101.99M | $100.58M | $101.53M | $101.01M |
| Total Liabilities and Total Equity | $19.94B | $19.97B | $20.18B | $20.54B | $15.70B | $5.21B | $5.28B | $5.06B | $5.10B | $5.14B | $5.13B | $5.12B | $5.18B | $4.41B | $4.36B | $4.37B | $4.41B | $4.33B | $4.33B | $4.34B |
| Total Investments | $936.81M | $931.84M | $992.49M | $930.56M | $782.85M | $72.07M | $73.80M | $75.09M | $77.72M | $79.61M | $161.18M | $75.67M | $69.79M | $78.56M | $73.41M | $75.54M | $77.75M | $61.11M | $62.68M | $64.32M |
| Total Debt | $9.02B | $8.89B | $9.14B | $9.30B | $7.08B | $2.10B | $2.11B | $1.87B | $1.92B | $1.99B | $2.01B | $2.00B | $2.02B | $1.50B | $1.42B | $1.50B | $1.51B | $1.44B | $1.42B | $1.51B |
| Net Debt | $8.90B | $8.71B | $8.98B | $9.14B | $6.97B | $1.90B | $1.87B | $1.86B | $1.92B | $1.99B | $2.01B | $2.00B | $2.01B | $1.49B | $1.42B | $1.49B | $1.51B | $1.44B | $1.41B | $1.50B |
Annual Cash Flow
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Net Income | $267.30M | $334.76M | $110.04M | $86.78M | $68.49M |
| Depreciation and Amortization | $1.06B | $749.90M | $189.64M | $157.87M | $149.59M |
| Deferred Income Tax | $-1.69M | $-14.61M | $-6.00M | $-12.12M | $6.33M |
| Stock Based Compensation | $31.77M | $15.00M | $26.46M | $18.20M | $17.37M |
| Change in Working Capital | $44.77M | $82.94M | $-10.77M | $255.00K | $1.89M |
| Accounts Receivables | $-40.86M | $- | $-7.65M | $-2.86M | $-1.40M |
| Inventory | $- | $- | $- | $- | $9.84M |
| Accounts Payables | $85.64M | $104.51M | $-2.26M | $-356.00K | $659.00K |
| Other Working Capital | $- | $-21.57M | $-861.00K | $3.47M | $-7.20M |
| Other Non Cash Items | $-328.86M | $-211.76M | $-40.17M | $-263.00K | $-5.49M |
| Net Cash Provided by Operating Activities | $1.07B | $956.24M | $258.40M | $247.56M | $233.30M |
| Investments in Property Plant and Equipment | $- | $- | $-39.87M | $-32.57M | $-33.89M |
| Acquisitions Net | $-115.16M | $-88.39M | $-13.59M | $-9.07M | $-18.39M |
| Purchases of Investments | $- | $- | $-156.65M | $-68.55M | $-14.43M |
| Sales Maturities of Investments | $- | $- | $65.80M | $68.55M | $14.43M |
| Other Investing Activities | $1.36M | $-488.36M | $105.83M | $-561.59M | $-149.64M |
| Net Cash Used for Investing Activities | $-113.80M | $-576.75M | $-38.47M | $-603.22M | $-201.91M |
| Debt Repayment | $153.22M | $378.08M | $324.58M | $-301.01M | $63.00M |
| Common Stock Issued | $317.00K | $278.00K | $308.10M | $5.04M | $1.07B |
| Common Stock Repurchased | $-190.69M | $-6.52M | $-67.84M | $-12.84M | $-10.53M |
| Dividends Paid | $-794.78M | $-657.02M | $-649.36M | $-650.08M | $-787.07M |
| Other Financing Activities | $-109.48M | $-52.12M | $-33.33M | $-329.62M | $-87.82M |
| Net Cash Used Provided by Financing Activities | $-941.42M | $-337.30M | $-222.07M | $363.03M | $-31.22M |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $-153.00K |
| Net Change in Cash | $15.28M | $42.19M | $-2.15M | $7.36M | $160.00K |
| Cash at End of Period | $184.31M | $169.02M | $7.73M | $9.88M | $2.52M |
| Cash at Beginning of Period | $169.02M | $126.83M | $9.88M | $2.52M | $2.35M |
| Operating Cash Flow | $1.07B | $956.24M | $258.40M | $247.56M | $233.30M |
| Capital Expenditure | $- | $- | $-39.87M | $-32.57M | $-33.89M |
| Free Cash Flow | $1.07B | $956.24M | $218.53M | $214.99M | $199.41M |
Cash Flow Charts
| Breakdown | December 31, 2024 | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | June 30, 2023 | March 31, 2023 | December 31, 2022 | September 30, 2022 | June 30, 2022 | March 31, 2022 | December 31, 2021 | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | June 30, 2020 | March 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $10.67M | $92.74M | $152.72M | $6.48M | $75.39M | $12.89M | $13.09M | $10.67M | $11.88M | $66.28M | $17.93M | $13.94M | $28.25M | $22.05M | $18.68M | $17.80M | $18.61M | $16.48M | $18.44M | $14.96M |
| Depreciation and Amortization | $274.47M | $280.02M | $283.50M | $219.22M | $188.54M | $49.26M | $49.31M | $49.04M | $43.18M | $48.40M | $49.23M | $48.84M | $43.21M | $38.58M | $38.10M | $37.98M | $37.85M | $37.95M | $37.05M | $36.75M |
| Deferred Income Tax | $-12.85M | $90.00K | $1.06M | $10.01M | $-13.36M | $940.00K | $49.00K | $-402.00K | $-802.00K | $-4.16M | $-959.00K | $-79.00K | $-13.69M | $-2.26M | $1.67M | $2.16M | $642.00K | $2.08M | $1.72M | $1.89M |
| Stock Based Compensation | $3.61M | $3.75M | $4.81M | $19.59M | $3.51M | $3.43M | $4.25M | $3.29M | $11.82M | $4.35M | $3.80M | $4.25M | $4.19M | $3.67M | $3.47M | $3.71M | $3.33M | $3.11M | $3.05M | $3.00M |
| Change in Working Capital | $-9.50M | $29.33M | $26.69M | $-1.75M | $13.65M | $-7.15M | $15.70M | $-2.70M | $-9.52M | $-4.03M | $16.36M | $-13.58M | $8.54M | $-8.43M | $19.63M | $-19.49M | $7.38M | $489.00K | $13.96M | $-19.93M |
| Accounts Receivables | $-42.93M | $-17.26M | $21.50M | $-2.17M | $-12.53M | $-2.94M | $3.08M | $567.00K | $-1.73M | $-4.25M | $-881.00K | $-791.00K | $50.00K | $-1.56M | $583.00K | $-1.94M | $-2.03M | $1.36M | $922.00K | $-1.66M |
| Inventory | $- | $- | $- | $- | $-3.97M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $10.95M | $-1.74M | $10.62M | $-9.99M |
| Accounts Payables | $33.44M | $- | $5.19M | $420.00K | $3.43M | $724.00K | $866.00K | $-1.05M | $-2.13M | $1.19M | $3.94M | $-5.25M | $891.00K | $336.00K | $2.77M | $-4.35M | $-1.11M | $4.28M | $1.14M | $-3.64M |
| Other Working Capital | $- | $46.59M | $- | $-2.17M | $26.71M | $-4.94M | $11.75M | $-2.22M | $-5.66M | $-964.00K | $13.30M | $-7.54M | $7.60M | $-7.21M | $16.29M | $-13.20M | $-424.00K | $-3.41M | $1.27M | $-4.64M |
| Other Non Cash Items | $17.13M | $-87.73M | $-152.58M | $363.92M | $-36.49M | $220.00K | $270.00K | $2.45M | $8.04M | $-47.98M | $-1.40M | $1.08M | $1.30M | $-198.00K | $-511.00K | $-855.00K | $-867.00K | $-1.48M | $-1.35M | $-1.80M |
| Net Cash Provided by Operating Activities | $283.53M | $318.20M | $316.20M | $159.85M | $231.25M | $60.13M | $82.07M | $63.72M | $56.05M | $62.85M | $84.96M | $54.53M | $71.81M | $53.40M | $81.04M | $41.30M | $66.94M | $58.63M | $72.87M | $34.86M |
| Investments in Property Plant and Equipment | $- | $- | $-35.72M | $-17.52M | $31.19M | $-11.74M | $-11.06M | $-8.40M | $-10.03M | $-8.32M | $-16.02M | $-5.49M | $-10.41M | $-8.65M | $-7.37M | $-6.14M | $-13.21M | $-8.87M | $-7.59M | $-4.21M |
| Acquisitions Net | $-7.15M | $-17.03M | $2.00K | $10.00K | $-39.91M | $-1.02M | $1.27M | $-180.00K | $-238.00K | $-1.23M | $-7.07M | $-5.04M | $-1.79M | $-7.29M | $-27.00K | $37.00K | $- | $-3.58M | $5.75M | $-396.35M |
| Purchases of Investments | $- | $- | $-139.12M | $-139.88M | $-198.52M | $-17.41M | $-45.75M | $-14.74M | $-2.10M | $-100.50M | $-215.59M | $-1.96M | $-604.49M | $8.65M | $7.37M | $6.14M | $- | $- | $- | $- |
| Sales Maturities of Investments | $- | $- | $352.17M | $229.17M | $20.47M | $13.46M | $27.60M | $2.54M | $47.65M | $-53.89M | $18.16M | $1.96M | $68.55M | $-4.76M | $-378.00K | $460.00K | $14.43M | $- | $- | $- |
| Other Investing Activities | $-226.62M | $47.26M | $1.73M | $-176.85M | $-28.91M | $556.00K | $1.13M | $-989.00K | $-32.07M | $169.48M | $161.14M | $22.72M | $63.88M | $-65.49M | $-25.78M | $-15.74M | $-114.20M | $-25.89M | $-24.50M | $-17.87M |
| Net Cash Used for Investing Activities | $-233.77M | $30.23M | $179.06M | $-105.06M | $-215.67M | $-16.14M | $-26.81M | $-21.77M | $3.21M | $5.53M | $-59.39M | $12.18M | $-484.25M | $-77.53M | $-26.18M | $-15.25M | $-112.99M | $-34.76M | $-32.09M | $-22.08M |
| Debt Repayment | $126.26M | $-26.07M | $-159.10M | $212.14M | $209.84M | $93.69M | $115.95M | $-41.40M | $-91.02M | $135.51M | $116.52M | $163.57M | $634.63M | $502.02M | $-854.47M | $-583.19M | $-8.62M | $-302.21M | $342.58M | $-98.34M |
| Common Stock Issued | $76.00K | $67.00K | $80.00K | $94.00K | $278.00K | $- | $- | $- | $308.06M | $- | $- | $- | $323.00K | $3.54M | $83.00K | $1.09M | $1.17M | $511.00K | $767.00K | $1.07B |
| Common Stock Repurchased | $-326.00K | $-20.14M | $-68.23M | $-102.00M | $226.00K | $22.00K | $-154.00K | $-6.62M | $-196.00K | $-56.02M | $-266.00K | $-11.36M | $-288.00K | $-73.00K | $-315.00K | $-12.16M | $-256.00K | $-275.00K | $-261.00K | $-9.74M |
| Dividends Paid | $-209.82M | $-209.82M | $-210.94M | $-164.20M | $-164.08M | $-164.01M | $-163.95M | $-164.98M | $-162.40M | $-161.68M | $-51.88M | $-52.86M | $-50.06M | $-50.06M | $-49.01M | $-49.71M | $-48.26M | $-48.24M | $-46.95M | $-44.53M |
| Other Financing Activities | $-23.69M | $-9.72M | $-63.39M | $-12.69M | $-6.74M | $-7.14M | $-11.35M | $-26.88M | $-6.78M | $-11.59M | $-8.00M | $-7.28M | $-73.29M | $-22.11M | $-68.48M | $-165.73M | $111.84M | $-24.27M | $-37.37M | $-8.43M |
| Net Cash Used Provided by Financing Activities | $-107.50M | $-265.68M | $-501.59M | $-66.66M | $39.49M | $-77.68M | $-59.63M | $-239.97M | $-54.04M | $-66.28M | $-27.90M | $-73.86M | $416.96M | $27.98M | $-57.29M | $-24.62M | $44.90M | $-24.09M | $-39.50M | $-12.53M |
| Effect of Forex Changes on Cash | $- | $- | $- | $- | $-114.59M | $114.59M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-143.00K | $-10.00K |
| Net Change in Cash | $-57.74M | $82.75M | $2.14M | $-11.87M | $55.10M | $-49.89M | $242.30M | $-4.37M | $5.22M | $2.11M | $-2.33M | $-7.15M | $4.51M | $3.85M | $-2.43M | $1.43M | $-1.15M | $-222.00K | $1.28M | $257.00K |
| Cash at End of Period | $184.31M | $242.04M | $159.29M | $157.16M | $169.02M | $195.77M | $245.66M | $3.36M | $7.73M | $2.51M | $401.00K | $2.73M | $9.88M | $5.37M | $1.52M | $3.95M | $2.52M | $3.67M | $3.89M | $2.61M |
| Cash at Beginning of Period | $242.04M | $159.29M | $157.16M | $169.02M | $113.93M | $245.66M | $3.36M | $7.73M | $2.51M | $401.00K | $2.73M | $9.88M | $5.37M | $1.52M | $3.95M | $2.52M | $3.67M | $3.89M | $2.61M | $2.35M |
| Operating Cash Flow | $283.53M | $318.20M | $324.67M | $159.85M | $231.25M | $60.13M | $82.07M | $63.72M | $56.05M | $62.85M | $84.96M | $54.53M | $71.81M | $53.40M | $81.04M | $41.30M | $66.94M | $58.63M | $72.87M | $34.86M |
| Capital Expenditure | $- | $- | $-35.72M | $-17.52M | $31.19M | $-11.74M | $-11.06M | $-8.40M | $-10.03M | $-8.32M | $-16.02M | $-5.49M | $-10.41M | $-8.65M | $-7.37M | $-6.14M | $-13.21M | $-8.87M | $-7.59M | $-4.21M |
| Free Cash Flow | $283.53M | $318.20M | $288.95M | $142.34M | $262.44M | $48.39M | $71.01M | $55.32M | $46.02M | $54.53M | $68.94M | $49.04M | $61.40M | $44.75M | $73.67M | $35.16M | $53.72M | $49.76M | $65.28M | $30.65M |
Healthpeak Properties Dividends
Explore Healthpeak Properties's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
5.80%
Dividend Payout Ratio
326.88%
Dividend Paid & Capex Coverage Ratio
1.35x
Healthpeak Properties Dividend History
| Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|
| $0.3 | $0.3 | February 13, 2024 | February 14, 2024 | February 26, 2024 | January 31, 2024 |
| $0.3 | $0.3 | November 06, 2023 | November 07, 2023 | November 20, 2023 | October 29, 2023 |
| $0.3 | $0.3 | August 04, 2023 | August 07, 2023 | August 18, 2023 | July 27, 2023 |
| $0.3 | $0.3 | May 05, 2023 | May 08, 2023 | May 19, 2023 | April 27, 2023 |
| $0.3 | $0.3 | February 08, 2023 | February 09, 2023 | February 23, 2023 | February 01, 2023 |
| $0.3 | $0.3 | November 04, 2022 | November 07, 2022 | November 18, 2022 | October 27, 2022 |
| $0.3 | $0.3 | August 05, 2022 | August 08, 2022 | August 19, 2022 | July 28, 2022 |
| $0.3 | $0.3 | May 06, 2022 | May 09, 2022 | May 20, 2022 | April 28, 2022 |
| $0.3 | $0.3 | February 10, 2022 | February 11, 2022 | February 22, 2022 | January 27, 2022 |
| $0.3 | $0.3 | November 05, 2021 | November 08, 2021 | November 19, 2021 | October 27, 2021 |
| $0.3 | $0.3 | August 06, 2021 | August 09, 2021 | August 20, 2021 | July 29, 2021 |
| $0.3 | $0.3 | May 07, 2021 | May 10, 2021 | May 21, 2021 | April 29, 2021 |
| $0.3 | $0.3 | February 19, 2021 | February 22, 2021 | March 05, 2021 | February 09, 2021 |
| $0.37 | $0.37 | November 10, 2020 | November 12, 2020 | November 23, 2020 | November 02, 2020 |
| $0.37 | $0.37 | August 13, 2020 | August 14, 2020 | August 25, 2020 | August 04, 2020 |
| $0.37 | $0.37 | May 07, 2020 | May 08, 2020 | May 19, 2020 | April 30, 2020 |
| $0.37 | $0.37 | February 14, 2020 | February 18, 2020 | February 28, 2020 | January 30, 2020 |
| $0.37 | $0.37 | November 01, 2019 | November 04, 2019 | November 19, 2019 | October 23, 2019 |
| $0.37 | $0.37 | August 02, 2019 | August 05, 2019 | August 20, 2019 | July 25, 2019 |
| $0.37 | $0.37 | May 03, 2019 | May 06, 2019 | May 21, 2019 | April 25, 2019 |
Healthpeak Properties News
Read the latest news about Healthpeak Properties, including recent articles, headlines, and updates.
5 Monthly-Paying REITs To Sleep Well At Night
This month's Mailbox Money report highlights five top monthly paying REITs, including new addition Healthpeak, with an average yield of 5.3% and an 18% annualized return forecast. Realty Income, STAG Industrial, Apple Hospitality, Agree Realty, and Healthpeak Properties are featured for their strong fundamentals, diversified portfolios, and attractive dividend yields ranging from 4.2% to 6.3%. Healthpeak Properties, now paying monthly dividends, offers a 6.1% yield and significant upside due to its focus on life science and outpatient medical properties.
Healthpeak Properties, Inc. (DOC) Q4 2024 Earnings Call Transcript
Healthpeak Properties, Inc. (NYSE:DOC ) Q4 2024 Earnings Conference Call February 4, 2025 10:00 AM ET Company Participants Andrew Johns - Senior Vice President, IR Scott Brinker - President and CEO Peter Scott - Chief Financial Officer Scott Bohn - Chief Development Officer & Head of Lab Tom Klaritch - Chief Operating Officer Conference Call Participants Nick Yulico - Deutsche Bank Juan Sanabria - BMO Capital Markets Austin Wurschmidt - Keybanc Capital Market Nick Joseph - Citigroup Richard Anderson - Wedbush Michael Carroll - RBC Capital Markets Mike Mueller - JPMorgan Jim Kammert - Evercore Vikram Malhotra - Mizuho Michael Stroyeck - Green Street Omotayo Okusanya - Deutsche Bank John Kilichowski - Wells Fargo Mason Guell - Baird Ronald Kamdem - Morgan Stanley James Feldman - Wells Fargo Operator Good morning. And welcome to the Healthpeak Properties, Inc.'s Fourth Quarter Conference Call.
HMS Networks has completed the acquisition of PEAK-System Technik
HMS Networks AB (publ) (“HMS”) has today completed the previously announced acquisition of 100 percent of the shares in PEAK-System Technik GmbH (“PEAK-System”), a well-established German provider of industrial communication solutions.
Healthpeak Properties, Inc. (DOC) Q3 2024 Earnings Call Transcript
Healthpeak Properties, Inc. (NYSE:DOC ) Q3 2024 Earnings Conference Call October 25, 2024 10:00 AM ET Company Participants Andrew Johns - Senior Vice President, IR Scott Brinker - President and CEO Peter Scott - Chief Financial Officer Scott Bohn - Chief Development Officer & Head of Lab Tom Klaritch - Chief Operating Officer Conference Call Participants Nick Yulico - Scotiabank Joshua Dennerlein - Bank of America Austin Wurschmidt - KeyBanc Capital Markets Juan Sanabria - BMO Capital Markets John Kilichowski - Wells Fargo Rich Anderson - Wedbush Michael Griffin - Citi Group Michael Carroll - RBC Capital Markets Derrick Metzler - Morgan Stanley Wes Golladay - Baird John Pawlowski - Green Street Jim Kammert - Evercore Mike Mueller - JPMorgan Operator Good morning. And welcome to the Healthpeak Properties, Inc.'s Third Quarter Conference Call.
HMS Networks acquires PEAK-System Technik and strengthens its position within Industrial Information and Communication Technology (ICT)
HMS Networks AB (publ) (“HMS”), a global provider of industrial information and communication technology, has today entered into a binding agreement with DOGAWIST-Investment GmbH to acquire 100% of the shares in PEAK-System Technik GmbH (“PEAK-System”), a well-established German provider of industrial communication solutions.
3 REITs With A Margin Of Safety
The margin of safety, introduced by Benjamin Graham, emphasizes diversification to protect against volatility and human errors, enhancing the probability of profitable outcomes. Healthpeak Properties, Plymouth Industrial REIT, and Realty Income are highlighted as REITs with a significant margin of safety, each rated as a Buy. Healthpeak Properties benefits from a merger, strong earnings, and a diversified healthcare portfolio, trading at a discount with a 5.45% dividend yield.
Healthpeak Properties: A 6.1% Yielding Healthcare Trust With Upside
Healthpeak Properties is a leading U.S. real estate investment trust focused on medical office buildings, poised for long-term growth. The merger with Physician Realty Trust has increased the trust's portfolio to 748 properties, with potential for $80 million in synergies. With a steady dividend and strong funds from operations growth, Healthpeak Properties is a compelling investment for passive income investors.
PEAK ROCK CAPITAL AFFILIATE COMPLETES PREVIOUSLY ANNOUNCED ACQUISITION OF HUFRIEDYGROUP
AUSTIN, Texas , June 3, 2024 /PRNewswire/ -- An affiliate of Peak Rock Capital ("Peak Rock"), a leading middle-market private equity firm, announced today that it has completed the previously announced acquisition of the dental segment ("HuFriedyGroup" or the "Company") of STERIS plc (NYSE:STE) ("STERIS"). Founded in 1908, HuFriedyGroup is a leading global manufacturer of high-quality instruments, infection prevention products, instrument management systems, and conscious sedation products for the dental industry.
Cogent Biosciences Announces Positive Updated Lead-In Data from Ongoing Phase 3 PEAK Trial Evaluating Bezuclastinib in Combination with Sunitinib in Patients with Gastrointestinal Stromal Tumors (GIST) at ASCO Annual Meeting
WALTHAM, Mass. and BOULDER, Colo., May 23, 2024 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced positive updated lead-in data from the company's ongoing Phase 3 PEAK trial evaluating the selective and potent KIT mutant inhibitor, bezuclastinib, in combination with sunitinib, in patients with Gastrointestinal Stromal Tumors (GIST). The data will be presented in a poster presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL on June 1. Cogent also announced today a new Phase 2 clinical trial of bezuclastinib plus sunitinib in later line GIST patients, sponsored by the Sarcoma Alliance for Research through Collaboration (SARC) and in collaboration with The Life Raft Group and Dana-Farber Cancer Institute.
Compound Your Wealth With These Undervalued Dividends
Planning for retirement requires a step-by-step approach and the power of compounding through dividend reinvestment and capital appreciation. Healthpeak Properties and Comcast are two undervalued picks with strong asset bases that offer potential for income and growth. Healthpeak Properties is a diversified healthcare REIT with a strong portfolio and a 6.4% dividend yield, while Comcast is a media giant with opportunities for growth in its broadband and streaming businesses.
The Top 3 REITs to Buy in April 2024
Research firm Nareit's prediction that 2024 will be a year that top REITs are “well-situated for outsized performance” hasn't yet come to fruition. Much of its predictive power rested on the assumption that the Fed would cut rates early in the year, which seems increasingly unlikely.
Healthpeak Properties to Present at the Citi 2024 Global Property CEO Conference and Publishes Updated Investor Presentation
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: PEAK), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced today that Scott Brinker, its President and Chief Executive Officer, is scheduled to present at the Citi 2024 Global Property CEO Conference. The presentation is scheduled for 11:40 a.m. Eastern Time on Tuesday, March 5, 2024. You can access the webcast by visiting our website at https://ir.healthpeak.com/news-events/default.
Healthpeak Properties Closes Merger with Physicians Realty Trust
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: PEAK) (“Healthpeak”) today announced that it has closed on the previously announced merger with Physicians Realty Trust. The combined company will operate under the name “Healthpeak Properties, Inc.” and is expected to begin trading under the ticker symbol “DOC” at the open of trading on The New York Stock Exchange on March 4, 2024. “We are pleased to announce the completion of our merger with Physicians Realty Trust,” said Scott Brink.
Healthpeak Properties, Inc. and Healthpeak OP, LLC Complete Consent Solicitation and Offers to Guarantee and Receive Required Consents to Amend Physicians Realty L.P. Indentures
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: PEAK) (“Healthpeak”) today announced that, in connection with its and Healthpeak OP, LLC's (“Healthpeak OP”) previously announced consent solicitation and offers to guarantee for Physicians Realty L.P. (a consolidated subsidiary of Physicians Realty Trust (NYSE: DOC) (“Physicians Realty Trust” or “DOC”)) senior notes related to Healthpeak's agreement to merge with Physicians Realty Trust (the “Merger”), it has received the required con.
Healthpeak Properties Stockholders and Physicians Realty Trust Shareholders Approve Merger
DENVER & MILWAUKEE--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: PEAK) (“Healthpeak”) and Physicians Realty Trust (NYSE: DOC) (“Physicians Realty Trust”) today announced that Healthpeak stockholders and Physicians Realty Trust shareholders have voted to approve the proposals necessary for the closing of the proposed merger at their respective special meetings held virtually today, February 21, 2024. The transaction is expected to close on or about March 1, 2024, subject to the satisfacti.
Healthpeak Properties, Inc. and Healthpeak OP, LLC Commence Consent Solicitation and Offers to Guarantee for Physicians Realty L.P. Senior Notes
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: PEAK) (“Healthpeak”) today announced, in connection with its previously announced agreement to merge with Physicians Realty Trust (NYSE: DOC) (“Physicians Realty Trust” or “DOC”), that it and Healthpeak OP, LLC (“Healthpeak OP”), a direct subsidiary of Healthpeak, have commenced a consent solicitation to certain proposed amendments to each of the supplemental indentures to the Senior Indenture (each an “Indenture”) governing the follow.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for PEAK.